Connor, Clark & Lunn Investment Management Ltd. Amneal Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 602,468 shares of AMRX stock, worth $6.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

602,468

Previous 527,685 14.17%

Holding current value

$6.17 Million

Previous $4.42 Million 10.2%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$6.97 - $8.23 $521,237 - $615,464	74,783 Added 14.17%	602,468 $4.87 Million
Q1 2025 May 12, 2025	SELL	$7.72 - $9.01 $215,928 - $252,009	-27,970 Reduced 5.03%	527,685 $4.42 Million
Q4 2024 Feb 10, 2025	BUY	$7.69 - $9.25 $51,369 - $61,790	6,680 Added 1.22%	555,655 $4.4 Million
Q3 2024 Nov 08, 2024	SELL	$6.42 - $8.83 $58,665 - $80,688	-9,138 Reduced 1.64%	548,975 $4.57 Million
Q2 2024 Aug 09, 2024	BUY	$5.36 - $7.11 $132,279 - $175,467	24,679 Added 4.63%	558,113 $3.54 Million
Q1 2024 May 09, 2024	BUY	$5.24 - $6.34 $296,206 - $358,387	56,528 Added 11.85%	533,434 $3.23 Million
Q4 2023 Feb 09, 2024	SELL	$3.36 - $6.21 $51,737 - $95,621	-15,398 Reduced 3.13%	476,906 $2.89 Million
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $295,568 - $491,543	107,090 Added 27.8%	492,304 $2.08 Million
Q2 2023 Aug 10, 2023	BUY	$1.33 - $3.1 $72,773 - $169,622	54,717 Added 16.56%	385,214 $1.19 Million
Q1 2023 May 09, 2023	BUY	$1.27 - $2.7 $122,402 - $260,226	96,380 Added 41.17%	330,497 $459,000
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $157,636 - $209,914	80,427 Added 52.33%	234,117 $465,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $310,453 - $556,357	153,690 New	153,690 $310,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $71,155 - $97,635	-18,014 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $994,927 - $1.48 Million	-281,053 Reduced 93.98%	18,014 $70,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $335,147 - $637,596	116,776 Added 64.06%	299,067 $1.42 Million
Q1 2020 May 13, 2020	BUY	$2.46 - $5.35 $448,435 - $975,256	182,291 New	182,291 $634,000

Others Institutions Holding AMRX

# of Institutions

250

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.55B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Amneal Pharmaceuticals, Inc. Transaction History